Edition:
United States

Curasan AG (CURG.DE)

CURG.DE on Xetra

1.44EUR
11:36am EDT
Change (% chg)

€0.06 (+4.26%)
Prev Close
€1.38
Open
€1.39
Day's High
€1.48
Day's Low
€1.35
Volume
26,769
Avg. Vol
37,957
52-wk High
€1.99
52-wk Low
€0.91

Latest Key Developments (Source: Significant Developments)

Curasan issues profit warning due to expected tax payment for 2008
Thursday, 22 Jun 2017 08:54am EDT 

June 22 (Reuters) - CURASAN AG ::PROFIT WARNING DUE TO EXPECTED TAX PAYMENT FOR 2008.IN Q2 OF 2017, THEREFORE, COMPANY WILL RECORD THIS RISK ACCORDINGLY, WHICH WILL WEIGH GROUP NET PROFIT AFTER TAX.‍FOLLOWING TALKS WITH FINANCIAL AUTHORITIES IN CONTEXT OF A TAX AUDIT CARRIED OUT SINCE 2013, THAT TAX CHARGES OF UP TO EUR 800 THOUSAND WILL BE RAISED AGAINST COMPANY​.‍THIS RELATES TO DENTAL BUSINESS ACTIVITIES ALREADY SOLD IN 2008 TO RIEMSER PHARMA GMBH AND THEIR VALUATION​.EARNINGS GUIDANCE RANGE IS UNLIKELY TO BE ACHIEVED WITH REGARD TO NET RESULT.‍STICKS TO ITS 2017 SALES INCREASE EXPECTATION. OPERATING BUSINESS IS NOT AFFECTED BY SPECIAL CHARGE​.  Full Article

Curasan Q1 net loss at 0.46 million euros
Thursday, 18 May 2017 02:00am EDT 

May 18 (Reuters) - CURASAN AG :GROSS SALES IN Q1 ROSE BY 15.9 PERCENT TO EUR 1.89 MILLION.Q1 NET PROFIT IMPROVED BY 8.7 PERCENT TO -0.46 MILLION EUROS.EBITDA IMPROVED BY 3.4 PERCENT (Q1 2016: -0.45 M EUR), WHILE EBIT REMAINED VIRTUALLY UNCHANGED AT -0.45 MILLION EUROS (Q1 2016: -0.45 M EUROS).  Full Article

Curasan launches CERASORB(R) Ortho Foam in US orthopedics market
Thursday, 11 May 2017 02:33am EDT 

May 11 (Reuters) - CURASAN AG ::LAUNCHES CERASORB(R) ORTHO FOAM IN US ORTHOPEDICS MARKET.  Full Article

Curasan sees 2017 net loss of EUR 1.6-2 mln, breakeven in 2018
Thursday, 27 Apr 2017 01:44am EDT 

April 27 (Reuters) - Curasan AG ::Curasan publishes annual report and details of outlook.Break even expected as of 2018.Gross sales revenues for full year 2016 rise by 16.1 percent to 6.9 million euros ($7.52 million).FY EBITDA at -2.1 million euros below previous year's figure, which was influenced by special effects.Deficit for year amounted to - 2.1 million euros, corresponding to a loss per share of - 0.21 euro.Based on internal budget planning process and expectations of external sales partners, company thus anticipates gross sales revenues between 8.5 million - 8.8 million euros in 2017.Management board therefore expects a target figure between -1.6 million and - 2.0 million euros for net result in 2017.  Full Article

Curasan enters into exclusive distribution partnership with China-based Fosun Group
Wednesday, 19 Apr 2017 03:06am EDT 

April 19 (Reuters) - Curasan AG :Enters into exclusive distribution partnership with China-based Fosun Group.Portfolio expansion and new permits planned for China.Anticipates a clear sales and revenue contribution for current 2017 fiscal year resulting from new distribution agreement, which will be offset by expected market entry costs.Expects to see positive earnings from partnership starting in 2018.  Full Article

Curasan appoints Christine Uekert new CFO
Monday, 3 Apr 2017 06:11am EDT 

Curasan AG : Christine Uekert: new CFO at Curasan . Has appointed Christine Uekert as chief financial officer with effect from 3 April .Uekert succeeds Erwin Amashaufer, who is retiring, in position as a management director.  Full Article

Curasan Q4 gross sales revenues up at EUR 2.11 mln
Thursday, 19 Jan 2017 03:58am EST 

Curasan AG : Gross sales revenues in Q4 rises by 37.0 percent to 2.11 million euros ($2.25 million) . Gross sales revenues at 6.94 million euros for fiscal year 2016 well within full-year forecast . For fiscal year 2017, management board of curasan ag expects sustained dynamic business performance . Anticipates gross sales revenues between 8.5 mln - 8.8 million for 2017 . Plans further increased investments in company's sales growth in order to gain larger shares of markets in asia and especially in United States .Management board therefore expects a target value between -1.6 mln and -2.2 million euros at level of net result for 2017.  Full Article

curasan successfully completes capital increase
Tuesday, 20 Dec 2016 01:29am EST 

curasan AG : Said on Monday successfully completes capital increase . Places all shares in the amount of 1,037,964 .Gross proceeds amount to around 1.00 million euros ($1.04 million).  Full Article

Curasan receives market clearance for orthopedic product in US market
Wednesday, 7 Dec 2016 02:00am EST 

Curasan AG : Receives market clearance for orthopedic product in the U.S. market . Structural reorganization of U.S. subsidiary successfully completed .FDA clearance of bone graft material CERASORB Ortho FOAM faster than expected.  Full Article

Curasan H1 gross revenues up 9.6 pct at EUR 3.35 mln
Thursday, 18 Aug 2016 02:00am EDT 

Curasan AG : Gross revenues in first half of year increase by 9.6 percent to 3.35 million euros ($3.79 million) . H1 EBITDA at -0.94 million euros was significantly below comparable figure influenced by out-of-court settlement payment to Stryker (first six months of 2015: +3.85 million euros) . Gross revenues in Q2 increase by 16.7 percent .'In next four quarters we expect significant contributions to sales from our previously announced sales offensives in United States and China," - CEO.  Full Article

BRIEF-Curasan issues profit warning due to expected tax payment for 2008

* IN Q2 OF 2017, THEREFORE, COMPANY WILL RECORD THIS RISK ACCORDINGLY, WHICH WILL WEIGH GROUP NET PROFIT AFTER TAX